2UH

N-[3-(propanoylamino)propyl]guanosine 5'-(trihydrogen diphosphate)

Created:	2014-05-08
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where 2UH is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	62
Chiral Atom Count	4
Bond Count	64
Aromatic Bond Count	5

2D diagram of 2UH

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[3-(propanoylamino)propyl]guanosine 5'-(trihydrogen diphosphate)
Systematic Name (OpenEye OEToolkits)	[(2R,3S,4R,5R)-3,4-bis(oxidanyl)-5-[6-oxidanylidene-2-[3-(propanoylamino)propylamino]-1H-purin-9-yl]oxolan-2-yl]methyl phosphono hydrogen phosphate
Formula	C₁₆ H₂₆ N₆ O₁₂ P₂
Molecular Weight	556.358
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=P(O)(O)OP(=O)(O)OCC3OC(n2cnc1c2N=C(NCCCNC(=O)CC)NC1=O)C(O)C3O
SMILES	CACTVS	3.385	CCC(=O)NCCCNC1=Nc2n(cnc2C(=O)N1)[CH]3O[CH](CO[P](O)(=O)O[P](O)(O)=O)[CH](O)[CH]3O
SMILES	OpenEye OEToolkits	1.9.2	CCC(=O)NCCCNC1=Nc2c(ncn2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)C(=O)N1
Canonical SMILES	CACTVS	3.385	CCC(=O)NCCCNC1=Nc2n(cnc2C(=O)N1)[C@@H]3O[C@H](CO[P](O)(=O)O[P](O)(O)=O)[C@@H](O)[C@H]3O
Canonical SMILES	OpenEye OEToolkits	1.9.2	CCC(=O)NCCCNC1=Nc2c(ncn2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)C(=O)N1
InChI	InChI	1.03	InChI=1S/C16H26N6O12P2/c1-2-9(23)17-4-3-5-18-16-20-13-10(14(26)21-16)19-7-22(13)15-12(25)11(24)8(33-15)6-32-36(30,31)34-35(27,28)29/h7-8,11-12,15,24-25H,2-6H2,1H3,(H,17,23)(H,30,31)(H2,27,28,29)(H2,18,20,21,26)/t8-,11-,12-,15-/m1/s1
InChIKey	InChI	1.03	CGASFCBZSMWGLJ-PMXXHBEXSA-N

Related Resource References

Resource Name	Reference
PubChem	137348087

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.